THE MOORCROFT MEDICAL CTR
10 BOTTESLOW STREET, STOKE ON TRENT
HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 17 | 18 | 94.4% | |
| HF 4 | 2011 | 14 | 18 | 77.8% | |
| HF 4 | 2012 | 19 | 26 | 73.1% | |
| HF 4 | 2013 | 23 | 26 | 88.5% | |
| HF004 | 2014 | 14 | 18 | 77.8% | |
| HF004 | 2015 | 21 | 23 | 91.3% | |
| HF004 | 2016 | 21 | 25 | 84.0% | |
| HF004 | 2017 | 17 | 20 | 85.0% | |
| HF004 | 2018 | 23 | 26 | 88.5% | |
| HF004 | 2019 | 50 | 57 | 87.7% | |
| HF004 | 2020 | 42 | 46 | 91.3% | |
| HF006 | 2021 | 42 | 43 | 97.7% | |
| HF006 | 2022 | 45 | 48 | 93.8% | |
| HF006 | 2023 | 44 | 44 | 100.0% |
